Micro Cap Already Off To The Races At The Bell

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, July 24, 2024

A New York-based biotech company is already off to the races so far during Wednesday’s session after the company announced that it signed an agreement with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype for Alzheimer’s disease.

Shares of Hoth Therapeutics Inc. (Nasdaq:HOTH) opened the day up at $1.27/share (+30.66%) at the bell, adding to yesterday’s strong performance and crossing over major SMAs. It should be an exciting session for this micro cap!

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.